Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Approximately 40% of global HIV-1 transmission occurs in the female genital tract (FGT) through heterosexual transmission. Epithelial cells lining the FGT provide the first barrier to HIV-1 entry. Previous studies have suggested that certain hormonal contraceptives or a dysbiosis of the vaginal microbiota can enhance HIV-1 acquisition in the FGT. We examined the effects of lactobacilli and female sex hormones on the barrier functions and innate immune responses of primary endometrial genital epithelial cells (GECs). Two probiotic strains, Lactobacillus reuteri RC-14 and L. rhamnosus GR-1, were tested, as were sex hormones estrogen (E2), progesterone (P4), and the hormonal contraceptive medroxyprogesterone acetate (MPA). Our results demonstrate that probiotic lactobacilli enhance barrier function without affecting cytokines. Treatment of GECs with MPA resulted in reduced barrier function. In contrast, E2 treatment enhanced barrier function and reduced production of proinflammatory cytokines. Comparison of hormones plus lactobacilli as a pre-treatment prior to HIV exposure revealed a dominant effect of lactobacilli in preventing loss of barrier function by GECs. In summary, the combination of E2 and lactobacilli had the best protective effect against HIV-1 seen by enhancement of barrier function and reduction in proinflammatory cytokines. These studies provide insights into how probiotic lactobacilli in the female genital microenvironment can alter HIV-1-mediated barrier disruption and how the combination of E2 and lactobacilli may decrease susceptibility to primary HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Estrogen has been shown to decrease inflammation, increase epithelial barrier integrity and promote Lactobacillus growth factors that enhance protection against infection in in vitro studies [4, 40].”
From Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial (2025) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908 · cited 1×
“Viral stocks were titered for infectious viral units per milliliter using the TZM-bl indicator cell assay as previously described [38].”
MethodVaginal Microbiome: Rethinking Health and Disease
Ma, B., Forney, L. J., & Ravel, J. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150157 · Cited by 729 · cited 4×
“A Lactobacillus rich environment has been shown to exert protective effects against urogenital 274 diseases, including BV, yeast infection, HSV-2, and HIV-1 [33].”
InfluentialGosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696 · cited 1×
“A decrease in Lactobacillus dominance and increased diversity is commonly associated with increased susceptibility to STIs including HIV-1, HSV-2, gonorrhea, and Chlamydia [31,32].”
BackgroundKarczewski, J., Troost, F. J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.-J. M., & Wells, J. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2009 · Cited by 676 · cited 1×
“In vitro studies using intestinal epithelial cells suggests that lactobacilli increase barrier function via tight-junction protein expression mediated by the TLR-2 pathway [53].”
BackgroundTargeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593 · cited 1×
“In order for HIV-1 to establish successful infection, the virus must cross the epithelial barrier in order to access target cells [10].”
BackgroundNazli, A., Chan, O., Dobson-Belaire, W. N., Ouellet, M., Tremblay, M. J., Gray-Owen, S. D., Arsenault, A. L., & Kaushic, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000852 · Cited by 593 · cited 7×
“This production decreases GEC barrier integrity and subsequent microbial translocation of HIV-1 across the upper female genital tract epithelium [11,12].”
BackgroundMethodSelf-citationHunt, P. W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 478
The role of sex hormones in immune protection of the female reproductive tract
Wira, C. R., Rodriguez-Garcia, M., & Patel, M. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3819 · Cited by 444 · cited 7×
“Furthermore, an increased susceptibility to sexually transmitted infections (STIs) including HIV-1 has been reported in women using the hormonal contraceptive DMPA [8,21,22,43].”
BackgroundInfluentialGenital Inflammation and the Risk of HIV Acquisition in Women
Masson, L., Passmore, J.-A. S., Liebenberg, L. J., Werner, L., Baxter, C., Arnold, K. B., Williamson, C., Little, F., Mansoor, L. E., Naranbhai, V., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ298 · Cited by 422 · cited 1×
“An inflammatory environment in the FGT is associated with a disruption in epithelial barrier function, which increases permeability between adjacent cells allowing microbial translocation of HIV-1 [11,44], and elevates production of proinflammatory TNF-α, causing further barrier damage [11].”
BackgroundLegrand, C., Bour, J. M., Jacob, C., Capiaumont, J., Martial, A., Marc, A., Wudtke, M., Kretzmer, G., Demangel, C., Duval, D., et al. (1992) · Journal of Biotechnology · doi:10.1016/0168-1656(92)90158-6 · Cited by 403
Impedance-based cell monitoring: barrier properties and beyond
Benson, K., Cramer, S., & Galla, H.-J. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-5 · Cited by 400
Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women
Mitchell, C. M., Haick, A., Nkwopara, E., Garcia, R., Rendi, M., Agnew, K., Fredricks, D. N., & Eschenbach, D. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.11.043 · Cited by 388 · cited 1×
“A decreased abundance of microbial species has also been identified in upper genital tract [28].”
BackgroundPudney, J., Quayle, A. J., & Anderson, D. J. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043133 · Cited by 373 · cited 1×
“Studies have demonstrated that upper genital tract, especially the transition zone between ecto and endo cervix is highly susceptible to HIV-1 infection [3,8,9].”
BackgroundHormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis
Morrison, C. S., Chen, P.-L., Kwok, C., Baeten, J. M., Brown, J., Crook, A. M., Van Damme, L., Delany-Moretlwe, S., Francis, S. C., Friedland, B. A., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001778 · Cited by 355 · cited 1×
“One such analysis found that DMPA increased women’s risk of contracting HIV-1 by 40 percent compared to those not using the contraceptive [19].”
BackgroundDoerflinger, S. Y., Throop, A. L., & Herbst-Kralovetz, M. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu004 · Cited by 315 · cited 1×
“A decrease in Lactobacillus dominance and increased diversity is commonly associated with increased susceptibility to STIs including HIV-1, HSV-2, gonorrhea, and Chlamydia [31,32].”
BackgroundVerstraelen, H., Vilchez-Vargas, R., Desimpel, F., Jauregui, R., Vankeirsbilck, N., Weyers, S., Verhelst, R., De Sutter, P., Pieper, D. H., & Van De Wiele, T. (2016) · PeerJ · doi:10.7717/peerj.1602 · Cited by 307
Roles and applications of probiotic Lactobacillus strains
Zhang, Z., Lv, J., Pan, L., & Zhang, Y. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9217-9 · Cited by 289 · cited 2×
“The ability of lactobacilli to reduce pathogen-induced inflammation also aligns with other studies [47,49].”
BackgroundResultInfluence of the Normal Menstrual Cycle on Vaginal Tissue, Discharge, and Microflora
Eschenbach, D. A., Thwin, S. S., Patton, D. L., Hooton, T. M., Stapleton, A. E., Agnew, K., Winter, C., Meier, A., & Stamm, W. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313818 · Cited by 288 · cited 2×
“The concept of applying probiotic lactobacilli to the vagina to displace pathogens and improve host defenses dates back to the mid-1980s but has more recent interest [34].”
BackgroundAl-Sadi, R., Guo, S., Ye, D., & Ma, T. Y. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.001 · Cited by 262
Wira, C. R., Fahey, J. V., Ghosh, M., Patel, M. V., Hickey, D. K., & Ochiel, D. O. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00842.x · Cited by 238
Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense
Valenti, P., Rosa, L., Capobianco, D., Lepanto, M. S., Schiavi, E., Cutone, A., Paesano, R., & Mastromarino, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00376 · Cited by 218
The role of molecular remodeling in differential regulation of tight junction permeability
Turner, J. R., Buschmann, M. M., Romero-Calvo, I., Sailer, A., & Shen, L. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.09.022 · Cited by 200 · cited 1×
“Subsequently, the increased proinflammatory cytokines result in further activation of myosin light chain kinase (MLCK) and myosin light chain (MLC) phosphorylation and cytoskeleton contraction, which induce delocalization of ZO-1 from tight junctions, thus causing disassembly junctional proteins [11,52].”
BackgroundHIV infection of the genital mucosa in women
Hladik, F., & Hope, T. J. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0004-1 · Cited by 184 · cited 1×
“Infection in women occurs primarily through heterosexual transmission in the female genital tract (FGT) with early mechanisms still not well understood [2].”
BackgroundPelekanou, V., Kampa, M., Kiagiadaki, F., Deli, A., Theodoropoulos, P., Agrogiannis, G., Patsouris, E., Tsapis, A., Castanas, E., & Notas, G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0914-430rr · Cited by 184 · cited 1×
“E2 has been shown in other cells to exert its anti-inflammatory effects through ERα and downregulation of NFkB-p65 expression [54].”
BackgroundVaginal microbiota and its role in HIV transmission and infection
Petrova, M. I., van den Broek, M., Balzarini, J., Vanderleyden, J., & Lebeer, S. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12029 · Cited by 178 · cited 1×
“Factors such as age, ethnicity, female sex hormones and use of HC have been shown to affect the composition and relative abundance of these species [29].”
BackgroundKozakova, H., Schwarzer, M., Tuckova, L., Srutkova, D., Czarnowska, E., Rosiak, I., Hudcovic, T., Schabussova, I., Hermanova, P., Zakostelska, Z., et al. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.09 · Cited by 159 · cited 2×
“The finding that probiotic lactobacilli can increase epithelial barrier function agrees with studies of both intestinal and genital tract systems [47,48].”
BackgroundNazli, A., Kafka, J. K., Ferreira, V. H., Anipindi, V., Mueller, K., Osborne, B. J., Dizzell, S., Chauvin, S., Mian, M. F., Ouellet, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301482 · Cited by 149 · cited 2×
“However, it is well established that HIV-1 binds to TLR-2 and TLR-4, thus activating the MAPK, PI3K, and NF-κB transcriptional pathways, resulting in up-regulation of proinflammatory cytokines [12,51].”
BackgroundSelf-citationGenital inflammation, immune activation and risk of sexual HIV acquisition
Passmore, J.-A. S., Jaspan, H. B., & Masson, L. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000232 · Cited by 144
Huijbregts, R. P. H., Helton, E. S., Michel, K. G., Sabbaj, S., Richter, H. E., Goepfert, P., & Hel, Z. (2013) · Endocrinology · doi:10.1210/en.2012-1850 · Cited by 133 · cited 11×
“The low cost, long-term effectiveness of DMPA as a contraceptive makes it an attractive choice for women.”
BackgroundInfluentialPolis, C. B., & Curtis, K. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70155-5 · Cited by 130 · cited 3×
“Human epidemiologic studies have shown an association between DMPA use and increased HIV-1 infection, disease progression and mortality [21,22].”
BackgroundNguyen, P. V., Kafka, J. K., Ferreira, V. H., Roth, K., & Kaushic, C. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.41 · Cited by 120 · cited 6×
“Furthermore, an increased susceptibility to sexually transmitted infections (STIs) including HIV-1 has been reported in women using the hormonal contraceptive DMPA [8,21,22,43].”
BackgroundSelf-citationKaushic, C., Roth, K., Anipindi, V. C., & Xiu, F. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.12.004 · Cited by 115
Self-citationBrotman, R. M., Ravel, J., Bavoil, P. M., Gravitt, P. E., & Ghanem, K. G. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.010 · Cited by 108
Chandra, N., Thurman, A. R., Anderson, S. M., Cunningham, T. D., Yousefieh, N., Mauck, C. K., & Doncel, G. F. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0271 · Cited by 106 · cited 11×
“The low cost, long-term effectiveness of DMPA as a contraceptive makes it an attractive choice for women.”
BackgroundInfluentialWessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102 · cited 4×
“Previous literature has indicated that both lactobacilli and E2 have beneficial effects in the FGT and have been implicated in protection against HIV-1 [8].”
BackgroundSelf-citationMucosal Immunity in the Female Genital Tract, HIV/AIDS
Machado, J. R., da Silva, M. V., Cavellani, C. L., dos Reis, M. A., Monteiro, M. L. G. D. R., Teixeira, V. D. P. A., & Corrêa, R. R. M. (2014) · BioMed Research International · doi:10.1155/2014/350195 · Cited by 93
Saba, E., Origoni, M., Taccagni, G., Ferrari, D., Doglioni, C., Nava, A., Lisco, A., Grivel, J., Margolis, L. B., & Poli, G. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.2 · Cited by 85 · cited 2×
“Several studies using animal models or ex vivo cervical explants have shown that E2 plays a protective role in HIV-1 infection, while P4 increases susceptibility to HIV-1 [41,42].”
BackgroundPolis, C. B., Phillips, S. J., Curtis, K. M., Westreich, D. J., Steyn, P. S., Raymond, E., Hannaford, P., & Turner, A. N. (2014) · Contraception · doi:10.1016/j.contraception.2014.07.009 · Cited by 84
Masson, L., Arnold, K. B., Little, F., Mlisana, K., Lewis, D. A., Mkhize, N., Gamieldien, H., Ngcapu, S., Johnson, L., Lauffenburger, D. A., et al. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052072 · Cited by 72 · cited 6×
“Furthermore, an increased susceptibility to sexually transmitted infections (STIs) including HIV-1 has been reported in women using the hormonal contraceptive DMPA [8,21,22,43].”
BackgroundInfluentialInflammation and HIV Transmission in Sub-Saharan Africa
Kaul, R., Prodger, J. L., Joag, V., Shannon, B., Yegorov, S., Galiwango, R. M., & McKinnon, L. R. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0269-5 · Cited by 67
The development of probiotics for women’s health
Reid, G. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2016-0733 · Cited by 66 · cited 3×
“The probiotic Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 were provided by Dr Gregor Reid, Lawson Health Research Institute, London, Ontario [35].”
BackgroundMethodSelf-citationThe effects of 17 alpha-estradiol to inhibit inflammation in vitro
Santos, R. S., de Fatima, L. A., Frank, A. P., Carneiro, E. M., & Clegg, D. J. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0151-9 · Cited by 49
Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
Ravel, J., Gajer, P., Fu, L., Mauck, C. K., Koenig, S. S. K., Sakamoto, J. M., Motsinger‐Reif, A. A., Doncel, G. F., & Zeichner, S. L. (2012) · mBio · doi:10.1128/mbio.00370-12 · Cited by 47 · cited 2×
“Molecular studies have identified more than 250 microbial species capable of growth within the vaginal tract [27].”
BackgroundInfluence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract
Ferreira, V. H., Kafka, J. K., & Kaushic, C. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12221 · Cited by 44
Self-citationCrook, A. M., Ford, D., Gafos, M., Hayes, R., Kamali, A., Kapiga, S., Nunn, A., Chisembele, M., Ramjee, G., Rees, H., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu113 · Cited by 40 · cited 3×
“Human epidemiologic studies have shown an association between DMPA use and increased HIV-1 infection, disease progression and mortality [21,22].”
BackgroundHerold, B. C., Keller, M. J., Shi, Q., Hoover, D. R., Carpenter, C., Huber, A. M., Parikh, U. M., Agnew, K. J., MINKOFF, H. L., Colie, C. F., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182961cfc · Cited by 38
Maritz, M. F., Ray, R. M., Bick, A. J., Tomasicchio, M., Woodland, J. G., Govender, Y., Avenant, C., & Hapgood, J. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196043 · Cited by 36 · cited 2×
“Furthermore, an 313 increased susceptibility to sexually transmitted infections (STIs) including HIV-1 has been reported 314 in women using the hormonal contraceptive DMPA [8,21,22,43].”
BackgroundWira, C. R., Rodríguez‐García, M., Shen, Z., Patel, M. V., & Fahey, J. V. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12235 · Cited by 35
Ferreira, V. H., Dizzell, S. E., Nazli, A., Kafka, J. K., Mueller, K., Nguyen, P. V., Tremblay, M. J., Cochrane, A., & Kaushic, C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu832 · Cited by 34 · cited 1×
“Sex hormones E2 (10−3 M), P4 (10−4 M) (purchased as water-soluble products, Sigma Aldrich, Oakville, ON, Canada), or MPA (10−3 M) (Sigma Aldrich) were prepared as stock in either water (E2, P4) or 100% ethanol (MPA) and diluted to the final working concentrations 10−9 M, 10−7 M and 10−9 M, respectively, in phenol-red–…”
MethodSelf-citationKaushic, C., Nazli, A., Ferreira, V. H., & Kafka, J. K. (2011) · Methods · doi:10.1016/j.ymeth.2011.09.022 · Cited by 25 · cited 1×
“The composition of the microbiota within the FGT influences HIV-1 susceptibility and may be regulated by female sex hormones [13,25,26].”
BackgroundSelf-citationHormonal contraceptive use and women's risk of HIV acquisition
Ralph, L. J., Gollub, E. L., & Jones, H. E. (2015) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000228 · Cited by 22
BRIND, J. L., Condly, S. J., Mosher, S. W., Morse, A., & Kimball, J. (2015) · PubMed · Cited by 22
Calla, N. E. Q., Miguel, R. D. V., Glick, M. E., Kwiek, J. J., Gabriel, J., & Cherpes, T. L. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25063 · Cited by 20
Woods, M. W., Zahoor, M. A., Dizzell, S. E., Verschoor, C. P., & Kaushic, C. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12781 · Cited by 19 · cited 2×
“Other studies have shown that that MPA treatment of primary endometrial GECs significantly upregulated genes for CCL20 and CXCL8 chemokines but did not lead to differential expression of genes related to the classical inflammatory cytokines [25].”
BackgroundSelf-citation
Cited by
Molina, N., Sola-Leyva, A., Saez-Lara, M., Plaza-Diaz, J., Tubić-Pavlović, A., Romero, B., Clavero, A., Mozas-Moreno, J., Fontes, J., & Altmäe, S. (2020) · Biomolecules · doi:10.3390/biom10040593 · Cited by 187
Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health
Zhu, B., Tao, Z., Edupuganti, L., Serrano, M. G., & Buck, G. A. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00181-21 · Cited by 156
“attenuation of HIV infections by these taxa (22, 55).”
BackgroundDelgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01337-5 · Cited by 146
“cultures in vitro has been demonstrated previously [31, 66].”
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Kamel, M. S., Aleya, S., Alsubih, M., & Aleya, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020217 · Cited by 114
“For instance, lactobacilli in the female genital tract produce lactic acid, inhibiting the growth of pathogenic yeasts and bacteria [42].”
BackgroundMicroorganisms in the reproductive system and probiotic's regulatory effects on reproductive health
Feng, T., & Liu, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.017 · Cited by 93
“rhamnosus GR-1) treatment can strengthen the barrier function of endometrial epithelial cells destroyed by human immunodeficiency virus-1 [109].”
Background
Metadata
- Authors
- Dizzell, S., Nazli, A., Reid, G., & Kaushic, C.
- Affiliations
- McMaster University (CA)
- Western University (CA)
- Corresponding author
- Kaushic, Charu
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-09-21
- Volume
- 8
- Issue
- 10
- Pages
- 1120
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6829272
- OpenAlex
- W2973607368
- Cited by
- 30
- References
- 54
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 2
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion, cc-by)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (FRN 126019, FRN 138657)
- Ontario HIV Treatment Network (AHRC 779)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV-1, female reproductive tract, epithelial barrier integrity, probiotic lactobacilli, Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, estrogen, medroxyprogesterone acetate, progesterone, hormonal contraception, inflammatory cytokines, vaginal microbiota, heterosexual transmission, innate immunity
- MeSH terms
- Adult, Antibiosis, Cell Membrane Permeability, Cells, Cultured, Epithelial Cells, Estradiol, Female, Genitalia, Female, Humans, Immunity, Innate, Lactobacillus, Middle Aged, Progesterone, HIV-1, HIV Infections, Cytoprotection, Probiotics, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.